相似文献
1
Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study.
Neurobiol Aging. 2013 Dec;34(12):2889.e11-3. doi: 10.1016/j.neurobiolaging.2013.06.004. Epub 2013 Jul 12.
2
Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
Neurobiol Aging. 2014 Dec;35(12):2681-2690. doi: 10.1016/j.neurobiolaging.2014.06.007. Epub 2014 Jun 17.
3
TREM2 variants in Alzheimer's disease.
N Engl J Med. 2013 Jan 10;368(2):117-27. doi: 10.1056/NEJMoa1211851. Epub 2012 Nov 14.
4
Variant of TREM2 associated with the risk of Alzheimer's disease.
N Engl J Med. 2013 Jan 10;368(2):107-16. doi: 10.1056/NEJMoa1211103. Epub 2012 Nov 14.
5
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
J Alzheimers Dis. 2013;35(1):45-9. doi: 10.3233/JAD-122311.
6
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
Neurobiol Aging. 2014 Feb;35(2):444.e1-4. doi: 10.1016/j.neurobiolaging.2013.08.011. Epub 2013 Sep 13.
7
TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.
JAMA Neurol. 2014 Apr;71(4):449-53. doi: 10.1001/jamaneurol.2013.6237.
8
More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk.
Neurobiol Aging. 2015 Aug;36(8):2443.e21-6. doi: 10.1016/j.neurobiolaging.2015.04.012. Epub 2015 Apr 25.
9
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
Alzheimers Dement. 2014 Nov;10(6):602-608.e4. doi: 10.1016/j.jalz.2014.05.1751. Epub 2014 Aug 23.
10
The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
Mol Neurodegener. 2018 Sep 6;13(1):49. doi: 10.1186/s13024-018-0280-6.
引用本文的文献
1
Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease.
Acta Pharm Sin B. 2025 Mar;15(3):1281-1310. doi: 10.1016/j.apsb.2024.11.016. Epub 2024 Nov 26.
2
An Update on Neuroaging on Earth and in Spaceflight.
Int J Mol Sci. 2025 Feb 18;26(4):1738. doi: 10.3390/ijms26041738.
3
Benefits and Challenges of Rare Genetic Variation in Alzheimer's Disease.
Curr Genet Med Rep. 2019 Mar;7(1):53-62. doi: 10.1007/s40142-019-0161-5. Epub 2019 Feb 1.
4
Reappraisal of the Concept of Accelerated Aging in Neurodegeneration and Beyond.
Cells. 2023 Oct 14;12(20):2451. doi: 10.3390/cells12202451.
5
The Alzheimer's disease-associated gene modulates inflammation by regulating microglia polarization and NLRP3 inflammasome activation.
Neural Regen Res. 2023 Feb;18(2):434-438. doi: 10.4103/1673-5374.346468.
6
The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer's disease: A systematic review and meta-analysis.
Exp Ther Med. 2021 Apr;21(4):347. doi: 10.3892/etm.2021.9778. Epub 2021 Feb 11.
7
Differential role of triggering receptors expressed on myeloid cells 2 R47H in 3 neurodegenerative diseases based on a systematic review and meta-analysis.
Medicine (Baltimore). 2020 Jan;99(5):e18921. doi: 10.1097/MD.0000000000018921.
8
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.
Nat Commun. 2019 Aug 21;10(1):3758. doi: 10.1038/s41467-019-11674-z.
9
A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
J Mol Neurosci. 2019 Nov;69(3):433-443. doi: 10.1007/s12031-019-01372-2. Epub 2019 Jul 25.
10
New insights into the role of TREM2 in Alzheimer's disease.
Mol Neurodegener. 2018 Dec 20;13(1):66. doi: 10.1186/s13024-018-0298-9.
本文引用的文献
1
Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions.
Biol Psychiatry. 2014 May 1;75(9):732-7. doi: 10.1016/j.biopsych.2013.07.008. Epub 2013 Aug 13.
2
Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.
Neurobiol Aging. 2013 Aug;34(8):2077.e11-8. doi: 10.1016/j.neurobiolaging.2013.02.016. Epub 2013 Apr 9.
3
TREM2 is associated with the risk of Alzheimer's disease in Spanish population.
Neurobiol Aging. 2013 Jun;34(6):1711.e15-7. doi: 10.1016/j.neurobiolaging.2012.12.018. Epub 2013 Feb 5.
4
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
J Alzheimers Dis. 2013;35(1):45-9. doi: 10.3233/JAD-122311.
5
Variant TREM2 as risk factor for Alzheimer's disease.
N Engl J Med. 2013 Jan 10;368(2):182-4. doi: 10.1056/NEJMe1213157. Epub 2012 Nov 14.
6
TREM2 variants in Alzheimer's disease.
N Engl J Med. 2013 Jan 10;368(2):117-27. doi: 10.1056/NEJMoa1211851. Epub 2012 Nov 14.
7
Variant of TREM2 associated with the risk of Alzheimer's disease.
N Engl J Med. 2013 Jan 10;368(2):107-16. doi: 10.1056/NEJMoa1211103. Epub 2012 Nov 14.
8
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Nat Genet. 2011 May;43(5):436-41. doi: 10.1038/ng.801. Epub 2011 Apr 3.
9
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.
Lancet. 2011 Feb 19;377(9766):641-9. doi: 10.1016/S0140-6736(10)62345-8. Epub 2011 Feb 1.
10
APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.
Neurology. 1999 Jul 22;53(2):321-31. doi: 10.1212/wnl.53.2.321.
Zotero 插件